Elevating the Role of Cardiologists in Diabetes Care: Cardiovascular Risk Reduction Strategies With GLP-1 Receptor Agonists

Join us for an interactive presentation where leading experts provide insight on strategies to reduce ASCVD risk in cardiology patients through the utilization of diabetes medications. Learn about GLP-1 receptor agonists, their role in cardiovascular risk reduction, and methods for implementing these agents into your practice.

Share

Program Content

Activities

CV RR GLP1
Cardiovascular Risk Reduction Strategies With GLP-1 Receptor Agonists
Slideset
Congratulations: You achieved a completion on 04/09/2022

Released: September 14, 2023

Activities

Integrate GLP-1s
Integrating GLP-1 RAs Into Your Cardiology Practice
PDF
Congratulations: You achieved a completion on 04/09/2022

Released: September 01, 2023

Activities

CV Risk Reduction in T2D
Cardiology Call to Action: Embracing Glucose-Lowering Treatment to Lower CV Risk in Patients With T2D
Clinical Thought
Congratulations: You achieved a completion on 04/09/2022

Released: October 17, 2023

Expires: October 17, 2024

GLP-1 RA Initiation in Cardiology
Strategies for Initiating and Managing GLP-1 RAs in Cardiology Practice
Clinical Thought
Congratulations: You achieved a completion on 04/09/2022

Released: October 30, 2023

Expires: October 30, 2024

Activities

MM1GLP1Cards
Medical Minute 1: Assessing the Need to Integrate GLP-1 RAs Into Cardiology Practice
Video
Congratulations: You achieved a completion on 04/09/2022

Released: November 10, 2023

Expires: November 09, 2024

MM2GLP1CVdata
Medical Minute 2: Cardiovascular Risk Reduction Strategies With GLP-1 Receptor Agonists
Multimedia
Congratulations: You achieved a completion on 04/09/2022

Released: November 13, 2023

Expires: November 12, 2024

Provided by

ProCE Banner

Provided by Clinical Care Options, LLC

Supporters

This activity is supported by an educational grant from Novo Nordisk.

Novo Nordisk